openPR Logo
Press release

Small Molecule Innovator CDMO Market Revenue, Growth Opportunities and Dynamic Business by 2031

07-01-2022 11:10 AM CET | IT, New Media & Software

Press release from: TMR Research

Small Molecule Innovator CDMO Market Revenue, Growth

Small Molecule Innovator CDMO Market - Overview

The global small molecule innovator CDMO market is anticipated to expand at a promising rate from 2021 to 2031 (forecast period). Small molecules are still crucial in the development of novel medicines all around the world. Small molecule applications account for more than half of specialty sales, which is propelling the global pharmaceutical business, particularly in developed countries.


Moreover, growing pharmaceutical R&D expenditure, rising demand, and the growing prevalence of cancer and age-related illnesses are the primary factors likely to drive the global small molecule innovator CDMO market during the forecast period.

Small Molecule Innovator CDMO Market - Competitive Landscape

Leading players in the small molecule innovator CDMO market are Siegfried holdings AG, Lonza Group Ltd., Patheon, Piramal Pharma Solutions, Catalent Inc., Wuxi AppTec, Recipharm AB, Cambrex Corporation, Corden Pharma International, Boehringer Ingelheim, Covance Inc., and Thermo Fisher Pantheon.

These players are adopting a variety of strategic initiatives in order to obtain a competitive edge over their competitors. Acquisitions, regional expansions, product launches, and mergers and acquisitions are all important factors influencing market competition. Corden Pharma, for example, stated in October 2020 that its Boulder, Colorado plant had completed the creation of a new, competent API laboratory. Customers can now access the new laboratory, which is capable of handling potent compounds with an OEL as low as 1 ng/m3.

Small Molecule Innovator CDMO Market - Trends and Opportunities

The global small molecule innovator CDMO market is expected to grow due to a surge in cancer cases and an increase in the need for effective oncology diagnostics, and R&D. Cancer is the top cause of mortality worldwide, per the WHO, with an anticipated 10 million deaths in 2020. Prostate, colorectal, lung, liver, and stomach cancers affect males, whereas breast, lung, colorectal, thyroid, and cervical cancers affect women.

The COVID-19 pandemic had a substantial influence on the world economy in 2020, and it continues to have an impact on numerous businesses. However, the global small molecule innovator CDMO market benefited from the pandemic. During this crisis, CDMOs are playing an essential role in satisfying the demands of biotech businesses, pharmaceutical corporations, and other end users.

Market players provide cost-effectiveness, time savings, and specialized knowledge to pharma, biotech, and other end-user industries. Overall, the outbreak has bolstered market growth. With pharma firms' increasing need for outsourcing, CDMOs are concentrating more on continual bioprocessing and process intensification.


Small Molecule Innovator CDMO Market - Regional Landscape

The Asia Pacific small molecule innovator CDMO market is anticipated to expand during the forecast period. The much lower manufacturing costs than in North America and Europe and favorable legislation are likely to drive regional market expansion. China is expected to be the largest revenue generator in small molecule innovator CDMO market in Asia Pacific.

Moreover, one of the important reasons projected to boost the regional market growth is an increased regulatory emphasis on quality control in manufacturing. The Ministry of Food and Drug Safety (MFDS) in South Korea, the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, and the Singapore Health Sciences Authority (HSA) in Singapore are among the regulatory agencies in Asia Pacific.


The small molecule innovator CDMO market in North America is projected to experience growth due to the presence of numerous well-known biotechnology, pharmaceutical, and medical device firms.

Moreover, the United States is likely to be the fastest growing market for small molecule innovator CDMO during the forecast period. Rising R&D investments by life sciences and pharmaceutical firms are expected to boost demand for contract manufacturing in the region. Furthermore, stringent rules on product development, production, and quality control are expected to increase demand for domestic contract manufacturing services.

About Us:
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today's supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients' conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Rohit Bhisey
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Visit Site:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Small Molecule Innovator CDMO Market Revenue, Growth Opportunities and Dynamic Business by 2031 here

News-ID: 2668875 • Views: 166

More Releases from TMR Research

Atmospheric Water Generator Market Dynamic Business Environment during 2021 - 20 …
Atmospheric Water Generator Market: Snapshot The global atmospheric water generator market is prognosticated to attract growth at a CAGR of 18.1% during the forecast period, between 2020 and 2027. Thus, the market is expected to be valued at US$ 6,214.9 Mn by 2027. The market was valued at US$ 1,940.8 Mn in 2019. The growth of the global atmospheric water generator market is ascribed to several factors including a rise in the
Facade Market Real Time Analysis & Forecast 2021 - 2031
Global Facade Market: Snapshot The global facade market is projected to attract growth at a CAGR of 6.4% during the forecast period, 2021-2028. The valuation of the market for facade was US$ 217.9 Bn in 2020. Fabrication, waterproofing, resistance to extreme climate, and durability are some of the key factors that play key role in the construction of facades. Companies operating in the global facade market are increasing efforts to develop technologically
Physician Office Laboratory (POL) Market Higher Growth Rate & Forecast 2021 - 20 …
Global Physician Office Laboratory (POL) Market: Snapshot The global Physician Office Laboratory (POL) Market has been expanding substantially over the last few years. Supported by the technological advancements, the market is likely to remain proliferating over the next few years. POL testing has its base in developed regions as emerging economies still rely on hospital infrastructure for the diagnosis of acute and chronic medical conditions. Developing regions, however, has been demonstrating
Extracorporeal Membrane Oxygenation (ECMO) Machine Market In-Depth Analysis & Fo …
Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market: Snapshot The global extracorporeal membrane oxygenation (ECMO) machine market is likely to be driven by the augmented government spending on the advancement and development of the product. The extracorporeal membrane oxygenation machine is the one that is similar to the device that is used in open-heart surgery. It oxygenates and pumps blood outof the body of the patient and enables lungs and heart to

All 5 Releases

More Releases for CDMO

Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Trends …
The industrial research report on ‘Contract Research Organization (CRO) and CDMO for Pharmaceutical Market’ offers in depth analysis on the crucial factors like market share, size, growth factors, drivers, and challenges. The report delivers actionable insights on these factors to help the business players, manufacturers, and marketing executives to plan operational strategies for the forecast period 2020 - 2025. Market Growth Insights Reports also studies the market from 360 degree perspective to
CDMO Market Size, Share, Trends, Analysis and Forecast 2020-2026
The global market for healthcare CDMO is projected to have considerable CAGR of around 7.6% during the forecast period. The major factor that driving the global healthcare CDMO market is the rising adoption of the outsourcing services by the pharmaceutical and biotechnology companies across the globe. Additionally, outsourcing the manufacturing in the pharmaceutical industry provide the companies to deviate workforce to other processing tasks which as a result makes monetary
Contract Research Organization (CRO) and CDMO for Pharmaceutical Market- Growth, …
The Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Report 2020 is a professional and in-depth study on the current state of the Contract Research Organization (CRO) and CDMO for Pharmaceutical Market. This report focuses on Contract Research Organization (CRO) and CDMO for Pharmaceutical volume and value at global level, regional level and company level. From a global perspective, this report represents overall Contract Research Organization (CRO) and CDMO
Global CMO/CDMO Market Production, Valuation and Sales Forecast 2019-2025 | Reci …
The report on the Global CMO/CDMO Market is prepared to help the stakeholders get a better perspective of the prevailing trends impacting its growth. The study provides in-depth knowledge of the Global CMO/CDMO Market, covering the impact of various regulations and policies adopted by the leading market players. The key drivers of the market, restrains, and trends influencing the Global CMO/CDMO Market are assessed through qualitative and quantitative investigation. The
Pharmaceutical CDMO Services Market | AMRI Global, Recipharm AB, Patheon N.V., C …
Global Pharmaceutical CDMO Services Market: Overview The demand within the global market for pharmaceutical CDMO services has been rising on account of the need develop safe and effective drugs for the treatment of multiple diseases and disorders. Contract Development and Manufacturing Organisations (CDMO) are offshoots of the pharmaceutical industry that help pharmaceutical companies in manufacturing, research, and development of drugs and other pharmaceutical products. CDMO provides key services such as research
CMO/CDMO Market Overview and Scope 2019 to 2025 | Kay Players Like Recipharm, AM …
Researchmoz added Most up-to-date research on "CMO/CDMO Market Overview and Scope 2019 to 2025 | Kay Players Like Recipharm, AMRI3, Patheon, Aenova and Catalent" to its huge collection of research reports. CMO/CDMO Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the CMO/CDMO industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics, Opportunities, Competitive